material assets material assetsmaterial assets … · abs, a colour masterbatch was added: a pure...
TRANSCRIPT
MATERIALS
Three key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home
healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This demands materials that meet functional,
aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved in home healthcare.
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.
Trinseo’s Magnum ABS resins use continuous mass polymerisation technology. This article discusses the main benefits of mass polymerisation over emulsion process technology here, followed by an overview of multiple performance tests, and findings that validate suitability for a healthcare environment.
With mass ABS different ingredients are added throughout a continuous process. Mass polymerisation cascades a series of reactors resulting in several chemical processes, specifically tuned for optimal rubber grafting and particle sizing. The process begins with a solution of uncrosslinked rubber dissolved in a mixture of monomers and solvent(s). At the end, the residual monomer and solvent is removed, leaving highly pure ABS.
Material Assets
Ben Porter, Trinseo, explains how the
company is meeting medical requirements
with its resins
In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.
Putting Magnum 8391 MED to the test
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
Magnum 8391 MED was compared with established, better-known, emulsion ABS resins.
TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, white base colour.
For aesthetic reasons, mass ABS is preferred because its whiter base colour is easier to self-colour, especially for light colours used in medical applications. It appears ‘cleaner’ and more visually appealing.
Figure 2: Natural resins manufactured through eABS versus mABS
Tests also measured colour differences based on the CIE LAB colour system which measures colour along three axes.
Figure 3: The CieLAB colour system
Figure 1: Emulsion vs. Mass ABS Production Process
moulded applications in the home health device market.moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on
tests show that Magnum suits a range of medical applications
moulding performance at different conditions; UV stability in
stringent material specifications. However, several Trinseo
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent,
aesthetically-appealing equipment. This
medical requirements with the Magnum ABS resins,
in water through a batch process. This requires high levels
polymer. The latex is then coagulated, producing an ABS
to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due
medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved demonstrating the potential benefits for customers involved in home healthcare. demonstrating the potential benefits for customers involved
explains how the explains how the Ben Porter, Trinseo,
explains how the Ben Porter, Trinseo,
medical requirements
aesthetically-appealing equipment. This demands materials that meet functional,
aesthetic, performance and haptic requirements. Therefore,
aesthetically-appealing equipment. This demands materials that meet functional,
the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant
polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded
in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
company is meeting
Material AssetsMaterial AssetsMaterial Assets
medical requirements with the Magnum ABS resins,
demand for home healthcare devices, demand for home healthcare devices, company is meeting
demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This with its resins
In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels
moulding performance at different conditions; UV stability in
tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices
With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.
TEST ONE: BASE COLOUR COMPARISON
Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.
TEST ONE: BASE COLOUR COMPARISON
moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.
These resins were designed for automotive applications,
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in
tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications
(diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.
stringent material specifications. However, several Trinseo
such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare
Magnum 8391 MED, making it Trinseo’s offering for injection
These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications,
8391 MED for medical applications, specifically: Base colour
stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo
such as housings for inhalers (asthma sprays), injection devices
aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins,
indoor exposure and residual volatiles levels.
Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting Magnum 8391 MED was compared with established, better-
known, emulsion ABS resins. known, emulsion ABS resins. known, emulsion ABS resins.
TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISON
devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due
a continuous process yields a resin with a highly consistent, Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISON
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting
medical requirements
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting
demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved
aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved demonstrating the potential benefits for customers involved demonstrating the potential benefits for customers involved in home healthcare.
medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved
Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved
aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved
aesthetic, performance and haptic requirements. Therefore, aesthetic, performance and haptic requirements. Therefore,
with its resins
Trinseo’s TS&D team is showing its capabilities in meeting
demands materials that meet functional, aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting Trinseo’s TS&D team is showing its capabilities in meeting Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, Trinseo’s TS&D team is showing its capabilities in meeting Trinseo’s TS&D team is showing its capabilities in meeting
Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-known, emulsion ABS resins. known, emulsion ABS resins. Magnum 8391 MED was compared with established, better-known, emulsion ABS resins. known, emulsion ABS resins. Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-known, emulsion ABS resins.
indoor exposure and residual volatiles levels.
Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-known, emulsion ABS resins.
TEST ONE: BASE COLOUR COMPARISON
Magnum 8391 MED was compared with established, better-known, emulsion ABS resins.
TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISON
devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection
(diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.
Magnum 8391 MED was compared with established, better-known, emulsion ABS resins. known, emulsion ABS resins.
Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.
devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.
devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.
devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection
Magnum 8391 MED was compared with established, better-known, emulsion ABS resins. known, emulsion ABS resins.
moulded applications in the home health device market.moulded applications in the home health device market.
devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.
These resins were designed for automotive applications,
medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved
These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications,
moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
These resins were designed for automotive applications, These resins were designed for automotive applications,
moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
Magnum 8391 MED was compared with established, better-
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo
Magnum 8391 MED was compared with established, better-stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications
suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications
(diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on
such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare
tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare
tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare
tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices
These resins were designed for automotive applications, These resins were designed for automotive applications,
moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting
tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices
stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices
stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices
These resins were designed for automotive applications,
stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications
to higher polymer processing aid loading. ABS produced in Magnum 8391 MED, making it Trinseo’s offering for injection
With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due
a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due
These resins were designed for automotive applications, These resins were designed for automotive applications,
tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare
tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, Magnum 8391 MED, making it Trinseo’s offering for injection a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due (diabetes), hand-held monitoring and other home healthcare
devices. Therefore, Trinseo obtained biocompatibility on
such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on
such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare
TEST ONE: BASE COLOUR COMPARISONsuch as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on
such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on
With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in devices. Therefore, Trinseo obtained biocompatibility on
Magnum 8391 MED, making it Trinseo’s offering for injection
TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications
medical requirements with the Magnum ABS resins,
These resins were designed for automotive applications, These resins were designed for automotive applications,
stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo
TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due
These resins were designed for automotive applications, These resins were designed for automotive applications,
in home healthcare.
These resins were designed for automotive applications,
medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved in home healthcare. demonstrating the potential benefits for customers involved in home healthcare.
These resins were designed for automotive applications,
in home healthcare. demonstrating the potential benefits for customers involved in home healthcare.
medical requirements with the Magnum ABS resins,
stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo known, emulsion ABS resins. known, emulsion ABS resins. known, emulsion ABS resins. known, emulsion ABS resins. stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices
stringent material specifications. However, several Trinseo known, emulsion ABS resins. known, emulsion ABS resins. stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo known, emulsion ABS resins.
TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISON
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting
tests show that Magnum suits a range of medical applications
suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications
suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo
These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo
These resins were designed for automotive applications, These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting
(diabetes), hand-held monitoring and other home healthcare
Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.
devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.moulded applications in the home health device market.
tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices
devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection
(diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices
moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection
In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels
with SAN to make an ABS resin for injection moulding. This
concentrate. Coagulation requires salts or acid to separate concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This with SAN to make an ABS resin for injection moulding. This
resin and the final product is more yellow. residuals. The compounding step adds thermal history to the resin and the final product is more yellow. resin and the final product is more yellow. resin and the final product is more yellow. resin and the final product is more yellow. residuals. The compounding step adds thermal history to the resin and the final product is more yellow. resin and the final product is more yellow. resin and the final product is more yellow.
8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour
moulding performance at different conditions; UV stability in
MATERIALSMATERIALS
Material Assets
MATERIALS
polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded
In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.
with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.
with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.
method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.
with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant
concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This
concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the
Material Assetshree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home
hree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home
Material AssetsMaterial Assetshree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home
healthcare. Material suppliers are adapting
In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the
In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
the polymer from the water. This concentrate is compounded
in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
for single-use devices, and the shift toward home healthcare. Material suppliers are adapting to support these market needs, developing
in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded the polymer from the water. This concentrate is compounded
polymer. The latex is then coagulated, producing an ABS
the polymer from the water. This concentrate is compounded
polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This with SAN to make an ABS resin for injection moulding. This
concentrate. Coagulation requires salts or acid to separate concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This with SAN to make an ABS resin for injection moulding. This
8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in
8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour
moulding performance at different conditions; UV stability in comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in
resin and the final product is more yellow.
Trinseo conducted tests to identify the market fit of Magnum
residuals. The compounding step adds thermal history to the resin and the final product is more yellow.
Trinseo conducted tests to identify the market fit of Magnum
resin and the final product is more yellow.
Trinseo conducted tests to identify the market fit of Magnum
resin and the final product is more yellow.
Putting Magnum 8391 MED to the test
Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour
polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate
residuals. The compounding step adds thermal history to the residuals. The compounding step adds thermal history to the
the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the
polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This
Material AssetsMaterial AssetsMaterial AssetsMaterial AssetsMaterial AssetsMaterial AssetsIn an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels
Material AssetsIn an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels in water through a batch process. This requires high levels In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate
residuals. The compounding step adds thermal history to the
in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the
concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the
in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded
Material AssetsMaterial AssetsMaterial AssetsIn an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the
aesthetically-appealing equipment. This demands materials that meet functional,
aesthetic, performance and haptic requirements. Therefore, aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins,
comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.indoor exposure and residual volatiles levels.
Magnum 8391 MED was compared with established, better-
explains how the company is meeting
medical requirements
explains how the company is meeting
medical requirements medical requirements
Ben Porter, Trinseo, explains how the
company is meeting medical requirements
Ben Porter, Trinseo,
aesthetically-appealing equipment. This demands materials that meet functional,
aesthetic, performance and haptic requirements. Therefore, demands materials that meet functional,
aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins,
aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins,
aesthetically-appealing equipment. This demands materials that meet functional,
aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting
company is meeting medical requirements demand for home healthcare devices, medical requirements
with its resins
demand for home healthcare devices, company is meeting
medical requirements with its resinswith its resins
demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This demands materials that meet functional,
aesthetic, performance and haptic requirements. Therefore,
medical requirements with its resins
demands materials that meet functional, aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /
medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved comparison, adding colour masterbatches; thermal stability /
moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in
pleasing. The latter trend is driven by demand for home healthcare devices,
with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant
Putting Magnum 8391 MED to the testPutting Magnum 8391 MED to the test
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum
comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in
8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in
Magnum 8391 MED was compared with established, better-
moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in
Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-
industry today are prevention of infection, demand for single-use devices, and the shift toward home industry today are prevention of infection, demand for single-use devices, and the shift toward home
hree key trends driving innovation in the medical device industry today are prevention of infection, demand hree key trends driving innovation in the medical device industry today are prevention of infection, demand hree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home Three key trends driving innovation in the medical device industry today are prevention of infection, demand
aesthetically-appealing equipment. This Putting Magnum 8391 MED to the test
aesthetically-appealing equipment. This
residuals. The compounding step adds thermal history to the resin and the final product is more yellow.
Putting Magnum 8391 MED to the testaesthetically-appealing equipment. This
pleasing. The latter trend is driven by demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This
with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.
industry today are prevention of infection, demand
healthcare. Material suppliers are adapting
hree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home
healthcare. Material suppliers are adapting
industry today are prevention of infection, demand
healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are
industry today are prevention of infection, demand for single-use devices, and the shift toward home
healthcare. Material suppliers are adapting
hree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home
healthcare. Material suppliers are adapting
industry today are prevention of infection, demand for single-use devices, and the shift toward home
healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are
industry today are prevention of infection, demand hree key trends driving innovation in the medical device industry today are prevention of infection, demand industry today are prevention of infection, demand
healthcare. Material suppliers are adapting for single-use devices, and the shift toward home
healthcare. Material suppliers are adapting healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are chemically resistant plastics which are
healthcare. Material suppliers are adapting to support these market needs, developing healthcare. Material suppliers are adapting to support these market needs, developing healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices,
the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This robust to sterilisation and aesthetically the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This robust to sterilisation and aesthetically
pleasing. The latter trend is driven by demand for home healthcare devices,
with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant
comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /
indoor exposure and residual volatiles levels.
Magnum 8391 MED was compared with established, better-
moulding performance at different conditions; UV stability in
Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-
moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.
Magnum 8391 MED was compared with established, better-
moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in
Magnum 8391 MED was compared with established, better-
moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in
Magnum 8391 MED was compared with established, better-
moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in
Magnum 8391 MED was compared with established, better-
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour
Putting Magnum 8391 MED to the test
Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum
Tindustry today are prevention of infection, demand for single-use devices, and the shift toward home Tindustry today are prevention of infection, demand
healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are Ben Porter, Trinseo, chemically resistant plastics which are robust to sterilisation and aesthetically chemically resistant plastics which are robust to sterilisation and aesthetically chemically resistant plastics which are robust to sterilisation and aesthetically
aesthetically-appealing equipment. This for which OEMs require non-industrial,
8391 MED for medical applications, specifically: Base colour
moulding performance at different conditions; UV stability in
Ben Porter, Trinseo, explains how the
Ben Porter, Trinseo, explains how the
Ben Porter, Trinseo, Ben Porter, Trinseo, explains how the
Ben Porter, Trinseo,
aesthetically-appealing equipment. This aesthetically-appealing equipment. This demands materials that meet functional,
aesthetic, performance and haptic requirements. Therefore, Putting Magnum 8391 MED to the test
for which OEMs require non-industrial, aesthetically-appealing equipment. This demands materials that meet functional,
for which OEMs require non-industrial,
chemically resistant plastics which are robust to sterilisation and aesthetically
Ben Porter, Trinseo, explains how the
company is meeting
to support these market needs, developing chemically resistant plastics which are robust to sterilisation and aesthetically
Ben Porter, Trinseo, robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices,
robust to sterilisation and aesthetically robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices,
company is meeting robust to sterilisation and aesthetically robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This
robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices, for which OEMs require non-industrial, demand for home healthcare devices,
moulding performance at different conditions; UV stability in
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in
8391 MED for medical applications, specifically: Base colour
Magnum 8391 MED was compared with established, better-
of emulsifiers (surfactants) to maintain a suspension of the of emulsifiers (surfactants) to maintain a suspension of the
a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due
a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due
a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,
Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-
In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the
In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the
In an emulsion process the reaction of monomers occurs
polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded
of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant
polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded
of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant
of emulsifiers (surfactants) to maintain a suspension of the of emulsifiers (surfactants) to maintain a suspension of the of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
In an emulsion process the reaction of monomers occurs
with SAN to make an ABS resin for injection moulding. This
polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This
of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant
of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS
method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the residuals. The compounding step adds thermal history to the residuals. The compounding step adds thermal history to the
8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in
Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-
comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in
Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour
residuals. The compounding step adds thermal history to the residuals. The compounding step adds thermal history to the
Trinseo conducted tests to identify the market fit of Magnum
residuals. The compounding step adds thermal history to the
Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum
method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the
Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum
Magnum 8391 MED was compared with established, better-
a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due
a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,
With emulsion ABS the end product has a yellower colour due
a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,
Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-
a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,
44 W W W . M E D I C A L P L A S T I C S N E W S . C O M
Here, colour data points are subdivided into three colour axes L, a and b, resulting in the final E value.
Colour comparisons were made based on three optical scenarios to capture different visible perceptions: Daylight; evening light with a higher yellow and red light fraction and artificial light representing a shopping environment.
Since Magnum 8391 MED offers a whiter colour than emulsion ABS, a colour masterbatch was added: a pure TiO2-based colour masterbatch with approximately 50% pigment loading, as the predominant colour in medical is white.
Figure 4 shows a first comparison divided into L, a and b values for a ‘medium-coloured’ ABS with 3% of masterbatch loading. Both grades show sufficient colour saturation which explains little difference on L values. The a values (“red/green”) are very close, too. The main difference is visible on b values, determining the yellow to blue differences. The emulsion ABS has a higher b value, relating to a more yellow color. This value has the most impact on the resulting ΔE value.
Figure 4: Competitive resin performance versus Magnum 8391 MED (with 3% white Masterbatch)
This observation is enforced when looking at a fairly ‘overloaded’ emulsion ABS with a 3% Magnum 8391 MED loading. Still, a higher Δb remains for the Emulsion ABS. So even with more than double the colour pigments loaded, this emulsion ABS can’t deliver the same white colour as Magnum 8391 MED, underlining the potential cost savings due to less use of colour masterbatches for white colours.
Figure 5: Competitive resin with 6.25% MB 744 versus 8391 Magnum MED
TEST TWO: THERMAL STABILITYTrinseo also measured differences in discoloration at molding temperatures of 220§C versus 300§C for both ABS types. The results show an average discoloration ΔE of 0.98 for MAGNUM ABS whereas the discoloration of emulsion ABS was around 1.25. This test shows that MAGNUM offers improved thermal stability. This translates to a more robust and stable converting process with a wide processing window. Emulsion ABS showed a higher discoloration of over 25%.
Figure 6: Thermal stability of MAGNUM ABS resins versus competitive resins in Daylight (D65), Evening light (A10) and Artificial light (F11)
TEST THREE: UV STABILITY As most hospital or home healthcare devices are designed for indoor use behind windows, a UV stability study was done. QUV-A represents a typical indoor exposure and was selected for this purpose: MAGNUM§ 8391 MED and incumbent emulsion ABS resins were exposed in the UV-2000 tester according to the following ASTM G154 conditions: U.V.-A 340 nm lamps; eight hrs UV at 60§C black panel temperature; four hours condensation at 50§C black panel temperature; E = 0.77W/m§
As mass and emulsion ABS offer different starting points regarding colour (yellowing level), the 3% white masterbatch (approx. 50% TiO2 pigment loading) was selected for UV investigations to put both materials at a comparable colour level.
Colour measurements were taken after 24, 48, 72 and 100 hour exposures. Due to less impurity in the final product, Magnum 8391 MED remains more colour stable over time.
Figure 7: Results for QUV-A (with 3% Masterbatch 744)
0
5
10
15
0 50 100
∆E
$me [hours]
QUV-‐A
compe**ve resin (Emulsion ABS + 3% MB 744 (white) Magnum 8391 + 3% MB 744 (white)
MATERIALS
222 dLdbdadE ++=
46 W W W . M E D I C A L P L A S T I C S N E W S . C O M
TEST FOUR: VOLATILESMany healthcare device providers want to minimise the migrating volatiles in materials for their devices. Regarding thermoplastics, the fraction of residual monomers, di- and trimeres are potentially relevant, as they are fairly volatile.
To determine the level of volatiles, a gas chromatography (GC) and high performance liquid chromatography (HPLC) are used. The cleaner manufacturing process helps Magnum 8391 MED to have a smaller volatile profile than competitive emulsion ABS.
Conclusion
Trinseo tests show clear advantages of using Magnum Mass ABS technology in the medical industry. A more compact product regarding volatiles, along with its purer base colour make Magnum 8391 MED suitable for medical device manufacturers. Magnum produced in a continuous mass ABS process results in a resin with a highly consistent, white base colour, making it suitable for easy and consistent self-colouring.
Self-colouring can be cost competitive and offers other benefits to OEMs and molders, letting a manufacturer buy a polymer resin and add colour masterbatch at the injection molding machine stage, instead of buying different compounded grades, which is costly. Trinseo can also offer pre-coloured options..
The superior natural base colour of Magnum resins is very attractive. Studies show high potential cost savings of around 50% for light colours due to less colour masterbatch usage.
Compared with emulsion, Magnum‘s beneficial UV stability means parts last longer, taking longer to discolour. The high purity and low residual volatiles offer benefits for medical applications. In summary, Magnum ABS resin offers a more stable and robust solution for converters and is a good market fit for medical applications, affording technical and economic benefits.
0
5
10
15
0 50 100
∆E
$me [hours]
QUV-‐A
compe**ve resin (Emulsion ABS + 3% MB 744 (white) Magnum 8391 + 3% MB 744 (white)
0 0.2 0.4 0.6 0.8 1
1.2 1.4 1.6
compe&&ve resin Magnum 8391 MED
vola&les [%]
Vola&le sec&on, determined by GC and HPLC Figure 8: Percent Volatiles of emulsion versus mass ABS
Figure 9: Lot-to-lot Consistency of ABS Resins versus Competitive Resins
MATERIALS
47W W W . M E D I C A L P L A S T I C S N E W S . C O M